The use of neuroimaging for assessing disorders of pituitary development

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 161-176

  Iorgi, Natascia D ^a   Allegri, Anna E M ^a   Napoli, Flavia ^a   Bertelli, Enrica ^a   Olivieri, Irene ^a   Rossi, Andrea ^b   Maghnie, Mohamad ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; PROTEIN; PROTEIN KAL1; PROTEIN PROKR2; RECOMBINANT GROWTH HORMONE; THYROTROPIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR SOX3; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ADENOHYPOPHYSIS DISEASE; ADENOHYPOPHYSIS DYSTOPIA; ADENOHYPOPHYSIS HYPOPLASIA; AGENESIS; BODY HEIGHT; CATCH UP GROWTH; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL DISORDER; EARLY DIAGNOSIS; FUNCTIONAL ANATOMY; GENE MUTATION; GENETIC COUNSELING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HETEROTOPIA; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS CELL; HYPOPHYSIS DISEASE; HYPOPHYSIS FUNCTION; HYPOPHYSIS SIZE; HYPOPITUITARISM; HYPOPLASIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KALLMANN SYNDROME; NEUROHYPOPHYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PERINATAL PERIOD; PHENOTYPE; PITUITARY STALK; PRENATAL PERIOD; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK FACTOR; TREATMENT RESPONSE;

ANIMALS; CELL DIFFERENTIATION; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; ORGAN SIZE; PITUITARY DISEASES; PITUITARY GLAND; PRENATAL DIAGNOSIS;

EID: 84855460854     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04238.x     Document Type: Review

References (109)

1. Tortori-Donati, P., Rossi, A., &, Biancheri, R., (2005) Sellar and Suprasellar Disorders. Springer, Berlin.
2. Sheng, H.Z., &, Westphal, H., (1999) Early steps in pituitary organogenesis. Trends in Genetics, 15, 236-240. (Pubitemid 29278677)
3. Kelberman, D., Rizzoti, K., Lovell-Badge, R., et al. (2009) Genetic regulation of pituitary gland development in human and mouse. Endocrine Reviews, 30, 790-829.
4. Righini, A., Parazzini, C., Doneda, C., et al. (2009) Prenatal MR imaging of the normal pituitary stalk. AJNR. American Journal of Neuroradiology, 30, 1014-1016.
5. Argyropoulou, M.I., Xydis, V., Kiortsis, D.N., et al. (2004) Pituitary gland signal in pre-term infants during the first year of life: an MRI study. Neuroradiology, 46, 1031-1035. (Pubitemid 40823331)
6. Takano, K., Utsunomiya, H., Ono, H., et al. (1999) Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR. American Journal of Neuroradiology, 20, 312-315. (Pubitemid 30418722)
7. Maghnie, M., Ghirardello, S., &, Genovese, E., (2004) Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. Journal of Endocrinological Investigation, 27, 496-509. (Pubitemid 38961265)
8. Fink, A.M., Vidmar, S., Kumbla, S., et al. (2005) Age-related pituitary volumes in prepubertal children with normal endocrine function: volumetric magnetic resonance data. Journal of Clinical Endocrinology and Metabolism, 90, 3274-3278. (Pubitemid 41014286)
9. Marziali, S., Gaudiello, F., Bozzao, A., et al. (2004) Evaluation of anterior pituitary gland volume in childhood using three-dimensional MRI. Pediatric Radiology, 34, 547-551. (Pubitemid 38967793)
10. Laumonnier, F., Ronce, N., Hamel, B.C., et al. (2002) Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. American Journal of Human Genetics, 71, 1450-1455. (Pubitemid 36015898)
11. Woods, K.S., Cundall, M., Turton, J., et al. (2005) Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. American Journal of Human Genetics, 76, 833-849. (Pubitemid 40563104)
12. Salemi, M., Romano, C., Ragusa, L., et al. (2007) A new 6-bp SOX-3 polyalanine tract deletion does not segregate with mental retardation. Genetic Testing, 11, 124-127. (Pubitemid 47041928)
13. Kelberman, D., de Castro, S.C., Huang, S., et al. (2008) SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. Journal of Clinical Endocrinology and Metabolism, 93, 1865-1873. (Pubitemid 351656532)
14. Alatzoglou, K.S., Kelberman, D., &, Dattani, M.T., (2009) The role of SOX proteins in normal pituitary development. Journal of Endocrinology, 200, 245-258.
15. Larsen, K.B., Lutterodt, M., Rath, M.F., et al. (2009) Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early human fetal retina. International Journal of Developmental Neuroscience, 27, 485-492.
16. Lemyre, E., Lemieux, N., Decarie, J.C., et al. (1998) Del(14)(q22.1q23.2) in a patient with anophthalmia and pituitary hypoplasia. American Journal of Medical Genetics, 77, 162-165. (Pubitemid 28211169)
17. Nolen, L.D., Amor, D., Haywood, A., et al. (2006) Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies. American Journal of Medical Genetics. Part A, 140, 1711-1718. (Pubitemid 44148231)
18. Dateki, S., Fukami, M., Sato, N., et al. (2008) OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. Journal of Clinical Endocrinology and Metabolism, 93, 3697-3702.
19. Tajima, T., Ohtake, A., Hoshino, M., et al. (2009) OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. Journal of Clinical Endocrinology and Metabolism, 94, 314-319.
20. Dateki, S., Kosaka, K., Hasegawa, K., et al. (2010) Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. Journal of Clinical Endocrinology and Metabolism, 95, 756-764.
21. Schilter, K.F., Schneider, A., Bardakjian, T., et al. (2011) OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clinical Genetics, 79, 158-168.
22. Diaczok, D., Romero, C., Zunich, J., et al. (2008) A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 93, 4351-4359. (Pubitemid 352789531)
23. Henderson, R.H., Williamson, K.A., Kennedy, J.S., et al. (2009) A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Molecular Vision, 15, 2442-2447.
24. Dattani, M.T., Martinez-Barbera, J.P., Thomas, P.Q., et al. (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics, 19, 125-133. (Pubitemid 28248792)
25. Dattani, M.T., &, Robinson, I.C., (2002) HESX1 and septo-optic dysplasia. Reviews in Endocrine & Metabolic Disorders, 3, 289-300. (Pubitemid 41448823)
26. Dattani, M.T., (2005) Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clinical Endocrinology, 63, 121-130. (Pubitemid 41097979)
27. Sobrier, M.L., Netchine, I., Heinrichs, C., et al. (2005) Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Human Mutation, 25, 503.
28. Reynaud, R., Albarel, F., Saveanu, A., et al. (2011) Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. European Journal of Endocrinology, 164, 457-465.
29. Sobrier, M.L., Maghnie, M., Vie-Luton, M.P., et al. (2006) Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. Journal of Clinical Endocrinology and Metabolism, 91, 4528-4536. (Pubitemid 44833435)
30. Sobrier, M.L., Attie-Bitach, T., Netchine, I., et al. (2004) Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expression Patterns, 5, 279-284. (Pubitemid 39618939)
31. Machinis, K., Pantel, J., Netchine, I., et al. (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. American Journal of Human Genetics, 69, 961-968. (Pubitemid 33015811)
32. Tajima, T., Hattori, T., Nakajima, T., et al. (2007) A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica. Endocrine Journal, 54, 637-641. (Pubitemid 47414615)
33. Pfaeffle, R.W., Hunter, C.S., Savage, J.J., et al. (2008) Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. Journal of Clinical Endocrinology and Metabolism, 93, 1062-1071. (Pubitemid 351398593)
34. Castinetti, F., Saveanu, A., Reynaud, R., et al. (2008) A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 93, 2790-2799. (Pubitemid 352008553)
35. Tajima, T., Yorifuji, T., Ishizu, K., et al. (2009) A novel mutation (V101A) of the LHX4 gene in a Japanese patient with combined pituitary hormone deficiency. Experimental and Clinical Endocrinology and Diabetes, 118, 405-409.
36. Dateki, S., Fukami, M., Uematsu, A., et al. (2010) Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. Journal of Clinical Endocrinology and Metabolism, 95, 4043-4047.
37. Roessler, E., Belloni, E., Gaudenz, K., et al. (1996) Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nature Genetics, 14, 357-360.
38. Roessler, E., Du, Y.Z., Mullor, J.L., et al. (2003) Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proceedings of the National Academy of Sciences of the United States of America, 100, 13424-13429. (Pubitemid 37444758)
39. Franca, M.M., Jorge, A.A., Carvalho, L.R., et al. (2010) Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. Journal of Clinical Endocrinology and Metabolism, 95, E384-E391.
40. Bertolacini, C., Ribeiro-Bicudo, L., Petrin, A., et al. (2010) Clinical findings in patients with GLI2 mutations-phenotypic variability. Clin Genet. 2010 Dec 6. doi: 10.1111/j.1399-0004.2010.01606.x. [Epub ahead of print].
41. Avbelij, M., Romero, C., Tziaferi, V., et al. (2009) New loci for congenital hypopituitarism: overlap with Kallman Syndrome. Abstract FC3-017 presented at the LWPES/ESPE 8th Joint Meeting Paediatric Endocrinology, NewYork. Hormone Research, 30-31.
42. Engelen, E., Akinci, U., Bryne, J.C., et al. (2011) Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nature Genetics, 43, 607-611.
43. Tatsumi, K., Miyai, K., Notomi, T., et al. (1992) Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genetics, 1, 56-58.
44. Miyata, I., Vallette-Kasic, S., Saveanu, A., et al. (2006) Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 4981-4987. (Pubitemid 44917338)
45. Pfaffle, R.W., DiMattia, G.E., Parks, J.S., et al. (1992) Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science, 257, 1118-1121.
46. Pellegrini-Bouiller, I., Belicar, P., Barlier, A., et al. (1996) A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 2790-2796. (Pubitemid 26323865)
47. Pfaffle, R.W., Martinez, R., Kim, C., et al. (1997) GH and TSH deficiency. Experimental and Clinical Endocrinology and Diabetes, 105 (Suppl 4), 1-5.
48. Turton, J.P., Reynaud, R., Mehta, A., et al. (2005) Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 90, 4762-4770. (Pubitemid 41159369)
49. Cohen, L.E., &, Radovick, S., (2002) Molecular basis of combined pituitary hormone deficiencies. Endocrine Reviews, 23, 431-442. (Pubitemid 34925640)
50. Wu, W., Cogan, J.D., Pfaffle, R.W., et al. (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics, 18, 147-149. (Pubitemid 28082461)
51. Cogan, J.D., Wu, W., Phillips, J.A., et al. (1998) The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 3346-3349. (Pubitemid 28500983)
52. Deladoey, J., Fluck, C., Buyukgebiz, A., et al. (1999) "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1645-1650. (Pubitemid 30644269)
53. Vieira, T.C., Boldarine, V.T., &, Abucham, J., (2007) Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arquivos brasileiros de endocrinologia e metabologia, 51, 1097-1103.
54. Bottner, A., Keller, E., Kratzsch, J., et al. (2004) PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. Journal of Clinical Endocrinology and Metabolism, 89, 5256-5265. (Pubitemid 39391475)
55. Turton, J.P., Mehta, A., Raza, J., et al. (2005) Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology, 63, 10-18. (Pubitemid 40966396)
56. Fofanova, O., Takamura, N., Kinoshita, E., et al. (2000) MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. AJR. American Journal of Roentgenology, 174, 555-559. (Pubitemid 30067177)
57. Riepe, F.G., Partsch, C.J., Blankenstein, O., et al. (2001) Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. Journal of Clinical Endocrinology and Metabolism, 86, 4353-4357. (Pubitemid 32848558)
58. Osorio, M.G., Marui, S., Jorge, A.A., et al. (2002) Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. Journal of Clinical Endocrinology and Metabolism, 87, 5076-5084. (Pubitemid 35331062)
59. Teinturier, C., Vallette, S., Adamsbaum, C., et al. (2002) Pseudotumor of the pituitary due to PROP-1 deletion. Journal of Pediatric Endocrinology and Metabolism, 15, 95-101. (Pubitemid 34704779)
60. Vallette-Kasic, S., Barlier, A., Teinturier, C., et al. (2001) PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 4529-4535. (Pubitemid 32848584)
61. Voutetakis, A., Argyropoulou, M., Sertedaki, A., et al. (2004) Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. Journal of Clinical Endocrinology and Metabolism, 89, 2200-2206. (Pubitemid 38619853)
62. Ward, R.D., Raetzman, L.T., Suh, H., et al. (2005) Role of PROP1 in pituitary gland growth. Molecular Endocrinology, 19, 698-710. (Pubitemid 40349441)
63. Netchine, I., Sobrier, M.L., Krude, H., et al. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics, 25, 182-186. (Pubitemid 30394989)
64. Bhangoo, A.P., Hunter, C.S., Savage, J.J., et al. (2006) Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 747-753. (Pubitemid 43357733)
65. Pfaeffle, R.W., Savage, J.J., Hunter, C.S., et al. (2007) Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. Journal of Clinical Endocrinology and Metabolism, 92, 1909-1919. (Pubitemid 46997209)
66. Rajab, A., Kelberman, D., de Castro, S.C., et al. (2008) Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Human Molecular Genetics, 17, 2150-2159. (Pubitemid 351911984)
67. Kristrom, B., Zdunek, A.M., Rydh, A., et al. (2009) A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations. Journal of Clinical Endocrinology and Metabolism, 94, 1154-1161.
68. Williamson, K.A., Hever, A.M., Rainger, J., et al. (2006) Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Human Molecular Genetics, 15, 1413-1422.
69. Fantes, J., Ragge, N.K., &, Lynch, et al., (2003) Mutations in SOX2 cause anophthalmia. Nature Genetics, 33, 461-463. (Pubitemid 36390005)
70. Ragge, N.K., Lorenz, B., Schneider, A., et al. (2005) SOX2 anophthalmia syndrome. American Journal of Medical Genetics. Part A, 135, 1-7; discussion 8. (Pubitemid 40627655)
71. Hagstrom, S.A., Pauer, G.J., Reid, J., et al. (2005) SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies. American Journal of Medical Genetics. Part A, 138A, 95-98. (Pubitemid 41384256)
72. Zenteno, J.C., Gascon-Guzman, G., &, Tovilla-Canales, J.L., (2005) Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene. Clinical Genetics, 68, 564-566. (Pubitemid 41748860)
73. Kelberman, D., Rizzoti, K., Avilion, A., et al. (2006) Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. Journal of Clinical Investigation, 116, 2442-2455. (Pubitemid 44330143)
74. Sisodiya, S.M., Ragge, N.K., Cavalleri, G.L., et al. (2006) Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia, 47, 534-542. (Pubitemid 43351557)
75. Sato, N., Kamachi, Y., Kondoh, H., et al. (2007) Hypogonadotropic hypogonadism in an adult female with a heterozygous hypomorphic mutation of SOX2. European Journal of Endocrinology, 156, 167-171. (Pubitemid 46554510)
76. Semina, E.V., Reiter, R., Leysens, N.J., et al. (1996) Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nature Genetics, 14, 392-399. (Pubitemid 26414582)
77. Tumer, Z., &, Bach-Holm, D., (2009) Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. European Journal of Human Genetics, 17, 1527-1539.
78. Hall, J.G., Pallister, P.D., Clarren, S.K., et al. (1980) Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly-a new syndrome? Part I: clinical, causal, and pathogenetic considerations. American Journal of Medical Genetics, 7, 47-74. (Pubitemid 11225708)
79. Johnston, J.J., Sapp, J.C., Turner, J.T., et al. (2010) Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Human Mutation, 31, 1142-1154.
80. Mullis, P.E., (2007) Genetics of growth hormone deficiency. Endocrinology and Metabolism Clinics of North America, 36, 17-36.
81. Salemi, S., Yousefi, S., Baltensperger, K., et al. (2005) Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion. European Journal of Endocrinology, 153, 791-802. (Pubitemid 43020229)
82. de Graaff, L.C., Baan, J., Govaerts, L.C., et al. (2008) Facial and pituitary morphology are related in Dutch patients with GH deficiency. Clinical Endocrinology, 69, 112-116. (Pubitemid 351847270)
83. Triulzi, F., Scotti, G., di Natale, B., et al. (1994) Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics, 93, 409-416. (Pubitemid 24067013)
84. Maghnie, M., Genovese, E., Villa, A., et al. (1996) Dynamic MRI in the congenital agenesis of the neural pituitary stalk syndrome: the role of the vascular pituitary stalk in predicting residual anterior pituitary function. Clinical Endocrinology, 45, 281-290. (Pubitemid 26306696)
85. Genovese, E., Maghnie, M., Beluffi, G., et al. (1997) Hypothalamic-pituitary vascularization in pituitary stalk transection syndrome: is the pituitary stalk really transected? The role of gadolinium-DTPA with spin-echo T1 imaging and turbo-FLASH technique. Pediatric Radiology, 27, 48-53. (Pubitemid 27042167)
86. Maghnie, M., Triulzi, F., Larizza, D., et al. (1991) Hypothalamic- pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. Journal of Clinical Endocrinology and Metabolism, 73, 79-83. (Pubitemid 21901103)
87. Argyropoulou, M., Perignon, F., Brauner, R., et al. (1992) Magnetic resonance imaging in the diagnosis of growth hormone deficiency. Journal of Pediatrics, 120, 886-891.
88. Chen, S., Leger, J., Garel, C., et al. (1999) Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. Journal of Clinical Endocrinology and Metabolism, 84, 2408-2413.
89. Pinto, G., Netchine, I., Sobrier, M.L., et al. (1997) Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. Journal of Clinical Endocrinology and Metabolism, 82, 3450-3454. (Pubitemid 27419104)
90. Maghnie, M., Larizza, D., Triulzi, F., et al. (1991) Hypopituitarism and stalk agenesis: a congenital syndrome worsened by breech delivery? Hormone Research, 35, 104-108.
91. Bressani, N., di Natale, B., Pellini, C., et al. (1990) Evidence of morphological and functional abnormalities in the hypothalamus of growth-hormone-deficient children: a combined magnetic resonance imaging and endocrine study. Hormone Research, 34, 189-192.
92. Abrahams, J.J., Trefelner, E., &, Boulware, S.D., (1991) Idiopathic growth hormone deficiency: MR findings in 35 patients. AJNR. American Journal of Neuroradiology, 12, 155-160.
93. Nagel, B.H., Palmbach, M., Petersen, D., et al. (1997) Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. European Journal of Pediatrics, 156, 758-763. (Pubitemid 27438794)
94. Kornreich, L., Horev, G., Lazar, L., et al. (1997) MR findings in hereditary isolated growth hormone deficiency. AJNR. American Journal of Neuroradiology, 18, 1743-1747. (Pubitemid 30399778)
95. Arends, N.J., V d LIP, W., Robben, S.G., et al. (2002) MRI findings of the pituitary gland in short children born small for gestational age (SGA) in comparison with growth hormone-deficient (GHD) children and children with normal stature. Clinical Endocrinology, 57, 719-724. (Pubitemid 36962998)
96. Cacciari, E., Zucchini, S., Ambrosetto, P., et al. (1994) Empty sella in children and adolescents with possible hypothalamic-pituitary disorders. Journal of Clinical Endocrinology and Metabolism, 78, 767-771.
97. Zenaty, D., Garel, C., Limoni, C., et al. (2003) Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Clinical Endocrinology, 58, 647-652. (Pubitemid 36566809)
98. Coutant, R., Rouleau, S., Despert, F., et al. (2001) Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. Journal of Clinical Endocrinology and Metabolism, 86, 4649-4654. (Pubitemid 33020502)
99. Maghnie, M., Ambrosini, L., Cappa, M., et al. (2006) Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. Journal of Clinical Endocrinology and Metabolism, 91, 2900-2905. (Pubitemid 44271733)
100. Maghnie, M., Strigazzi, C., Tinelli, C., et al. (1999) Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. Journal of Clinical Endocrinology and Metabolism, 84, 1324-1328. (Pubitemid 30644394)
101. Adan, L., Souberbielle, J.C., &, Brauner, R., (1994) Diagnostic markers of permanent idiopathic growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 353-358. (Pubitemid 24061753)
102. Murray, P.G., Hague, C., Fafoula, O., et al. (2009) Likelihood of persistent GH deficiency into late adolescence: relationship to the presence of an ectopic or normally sited posterior pituitary gland. Clinical Endocrinology, 71, 215-219.
103. Clayton, P.E., Cuneo, R.C., Juul, A., et al. (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. European Journal of Endocrinology, 152, 165-170. (Pubitemid 40309560)
104. Ho, K.K., (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology, 157, 695-700.
105. Leger, J., Danner, S., Simon, D., et al. (2005) Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood? Journal of Clinical Endocrinology and Metabolism, 90, 650-656. (Pubitemid 40279175)
106. Maghnie, M., Aimaretti, G., Bellone, S., et al. (2005) Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. European Journal of Endocrinology, 152, 589-596. (Pubitemid 40575804)
107. Secco, A., di Iorgi, N., Napoli, F., et al. (2009) Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing. Journal of Clinical Endocrinology and Metabolism, 94, 4195-4204.
108. di Iorgi, N., Secco, A., Napoli, F., et al. (2007) Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study. Journal of Clinical Endocrinology and Metabolism, 92, 3875-3884. (Pubitemid 47607636)
109. Maghnie, M., Uga, E., Temporini, F., et al. (2005) Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. European Journal of Endocrinology, 152, 735-741. (Pubitemid 40744542)